Targeting ERβ function may be a potential therapeutic option since it is highly expressed in the brain, specifically in cortical regions responsible for executive functions significantly affected in HIV-1 associated neurocognitive disorders (HAND) [35], [52]–[54]. Here, ESR2 is linked to HIV-associated neurocognitive disorder.